Predictive values of multiple non-invasive markers for myocardial fibrosis in hypertrophic cardiomyopathy patients with preserved ejection fraction
Abstract Myocardial fibrosis assessed by late gadolinium enhancement (LGE) on cardiovascular magnetic resonance (CMR) is associated with cardiovascular outcomes in hypertrophic cardiomyopathy (HCM) patients, but little is known about the utility of non-invasive markers for detecting LGE. This study...
Guardado en:
Autores principales: | Yumin Li, Jia Liu, Yukun Cao, Xiaoyu Han, Guozhu Shao, Xiaoyue Zhou, Jin Gu, Tong Liu, Yue Cui, Heshui Shi |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b986432197a14a2dac0bb30da0b99893 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Survival in Patients With Nonischemic Cardiomyopathy With Preserved vs Reduced Ejection Fraction
por: Nancy Luo, MD, MHS, et al.
Publicado: (2021) -
Left ventricular fibrosis and hypertrophy are associated with mortality in heart failure with preserved ejection fraction
por: Pankaj Garg, et al.
Publicado: (2021) -
Age, creatinine clearance, and ejection fraction (mACEF) score predicts long-term cardiac mortality in patients with hypertrophic obstructive cardiomyopathy treated non-invasively
por: Jun Gao, et al.
Publicado: (2021) -
Management of Hypertrophic Cardiomyopathy
por: Alan D. Enriquez, et al.
Publicado: (2014) -
Plasma microrna expression profile for reduced ejection fraction in dilated cardiomyopathy
por: Maria Calderon-Dominguez, et al.
Publicado: (2021)